Co-Authors
This is a "connection" page, showing publications co-authored by Robert Flisiak and Krzysztof Tomasiewicz.
Connection Strength
4.019
-
Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study. Expert Rev Anti Infect Ther. 2021 01; 19(1):93-100.
Score: 0.895
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021. Pol Arch Intern Med. 2021 05 25; 131(5):487-496.
Score: 0.236
-
Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6. J Clin Med. 2021 Apr 09; 10(8).
Score: 0.235
-
Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study. Pol Arch Intern Med. 2021 01 29; 131(1):103-110.
Score: 0.230
-
Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study. J Clin Med. 2020 Dec 24; 10(1).
Score: 0.230
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020. Pol Arch Intern Med. 2020 10 29; 130(10):915-918.
Score: 0.228
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 1 as of June 8, 2020. Pol Arch Intern Med. 2020 06 25; 130(6):557-558.
Score: 0.222
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020. Pol Arch Intern Med. 2020 04 30; 130(4):352-357.
Score: 0.219
-
Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study. Adv Med Sci. 2017 Sep; 62(2):387-392.
Score: 0.179
-
Recommendations for the treatment of hepatitis C in 2017. Clin Exp Hepatol. 2017 Jun; 3(2):47-55.
Score: 0.179
-
Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016 Dec; 2(4):138-143.
Score: 0.173
-
Prevalence of HCV genotypes in Poland - the EpiTer study. Clin Exp Hepatol. 2016 Dec; 2(4):144-148.
Score: 0.173
-
Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016. Clin Exp Hepatol. 2016 Jun; 2(2):27-33.
Score: 0.166
-
Effect of hepatitis B virus (HBV) infection on the course of pregnancy and newborns' health status. Clin Exp Hepatol. 2015 Nov; 1(3):112-116.
Score: 0.161
-
Distribution of HBV genotypes in Poland. Clin Exp Hepatol. 2015 May; 1(1):1-4.
Score: 0.155
-
Forecasting the disease burden of chronic hepatitis C virus in Poland. Eur J Gastroenterol Hepatol. 2015 Jan; 27(1):70-6.
Score: 0.152
-
Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study. Clin Exp Hepatol. 2019 Sep; 5(3):215-223.
Score: 0.053
-
Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals? J Interferon Cytokine Res. 2018 02; 38(2):93-100.
Score: 0.047
-
Recommendations for the treatment of hepatitis B in 2017. Clin Exp Hepatol. 2017 Jun; 3(2):35-46.
Score: 0.045
-
Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015. Clin Exp Hepatol. 2015 Nov; 1(3):97-104.
Score: 0.040